Nasdaq · Healthcare
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
As-reported financials and recent SEC filings for LIFECORE BIOMEDICAL, INC. \DE\, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$128.9M
Net income
$-38.7M
Net margin
-30.0%
Diluted EPS
$-1.27
ROE
-2898.0%
P/E (TTM)
—
Market cap
—
Debt / equity
97.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $128.9M | $128.3M | $103.3M | $111.3M | $100.9M |
| Gross profit | $40.3M | $41.9M | $28.0M | $39.1M | $38.9M |
| Operating income | $-17.2M | $-8.8M | $-21.8M | $-11.8M | $-8.8M |
| Net income | $-38.7M | $12.0M | $-99.6M | $-116.7M | $-32.3M |
| Diluted EPS | $-1.27 | $0.33 | $-3.32 | $-3.97 | $-1.10 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SCHEDULE 13D/A2026-07-02
View on EDGAR →8-K2026-07-02
View on EDGAR →SCHEDULE 13D/A2026-07-02
View on EDGAR →42026-06-08
View on EDGAR →42026-06-05
View on EDGAR →42026-06-05
View on EDGAR →42026-06-05
View on EDGAR →42026-06-05
View on EDGAR →Largest Healthcare peers
Go deeper on LFCR
Search LIFECORE BIOMEDICAL, INC. \DE\’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.